EGFR and head and neck squamous cell carcinoma: Additionally, the soluble extracellular domain of the marker of epithelial differentiation EpCAM termed EpEX, which is generated through regulated intramembrane proteolysis [22], was identified as a novel ligand of EGFR that induces a mild proliferation and counteracts EGFR-mediated EMT in HNSCC [21].